Company Filing History:

4 out of 5,069

Centre National De La Recherche Scientifique

patents

3 out of 119

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

patents

1 out of 6

Societe D'expansion Scientifique Expansia

patents

Years Active: 1993-2004

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6784194 - Therapeutic use of a thienylcyclohexylamine derivative (2004-08-31),

2. 6514967 - Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same (2003-02-04),

3. 6342511 - Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same (2002-01-29),

4. 6207685 - Therapeutic application of a thienycyclohexylamine derivative (2001-03-27),

5. 6107495 - Thienylcyclohexane derivatives for thienylcyclohexyl synthesis (2000-08-22),

6. 5972952 - Neuroprotective pharmaceutical composition containing stereoisomers of (1999-10-26),

7. 5248686 - Substituted cyclic amines and pharmaceutical composition containing them (1993-09-28),

8. 5179109 - Pharmaceutical compositions for neuroprotection containing (1993-01-12),

Title: The Innovations of Jean-Marc Kamenka

Introduction

Jean-Marc Kamenka is a notable inventor based in Montpellier, France. He has made significant contributions to the field of therapeutic applications, holding a total of 8 patents. His work focuses on innovative methods to combat neurotoxic effects in warm-blooded animals.

Latest Patents

Among his latest patents is a method for inhibiting the effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals. This involves administering a reversible cholinesterase inhibitor, such as pyridostigmine or physostigmine, followed by a specific compound in a pure form. Another significant patent involves the preparation of medicines for treating pathologies related to extracellular glutamate, along with methods for obtaining these compounds.

Career Highlights

Jean-Marc Kamenka has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS). His career reflects a commitment to advancing scientific knowledge and therapeutic practices.

Collaborations

Throughout his career, Kamenka has collaborated with esteemed colleagues, including Alain Privat and Guy Lallement. These partnerships have contributed to the development of his innovative ideas and patents.

Conclusion

Jean-Marc Kamenka's contributions to the field of therapeutics demonstrate his dedication to innovation and research. His patents reflect a deep understanding of neurotoxicology and its implications for warm-blooded animals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.